Tag Archives: Business Wire

Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

BOSTON–(BUSINESS WIRE)–The following Eaton Vance closed-end funds (the “Funds”) announced distributions today as detailed below. Declaration – 4/3/2023 Ex-Date – 4/12/2023 Record – 4/13/2023 Payable – 4/20/2023   Municipal Bond Funds: Fund Ticker Distribution Change From Prior Distribution Closing Market Price – 3/31/23 Distribution Rate at Market Price Eaton Vance California Municipal Income Trust CEV $0.0371 – $10.23 4.35% Eaton Vance Municipal Income Trust EVN $0.0410 – $10.13 4.86%     Ta

Enveric Biosciences Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today provided a corporate update and reported financial results for the fourth quarter and year ended December 31, 2022. “Enveric is a transformed company; 2022 was a year of considerable accomplishments, and we are now poised for an a

Smithers Announces Vice President of Operations, North America, Environmental Risk Sciences Division

WAREHAM, Mass.–(BUSINESS WIRE)– #ecotoxicology–Smithers, a leading provider of testing, consulting, information, and compliance services, announces the appointment of Glen (Gus) Zieske as Vice President, North America, Environmental Risk Sciences Division. In this role, Gus will have leadership responsibilities for the Smithers North American team of experts who provide environmental testing services in the areas of ecotoxicology, environmental fate, plant and animal metabolism, and product and residue chemi

Aelis Farma Reports Its 2022 Annual Financial Results and Confirms Its 2023 Outlook

BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, today announced its annual results for the year to December 31, 2022. Pier Vincenzo Piazza, CEO of Aelis Farma, said: “2022 was marked by a number of key events for Aelis Farma, beginning with our IPO, which enabled us to raise substantial financial resour

Tenet to Report its First Quarter 2023 Results on April 25th

DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (NYSE: THC) will release its first quarter 2023 results before the market opens on Tuesday, April 25, 2023, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services comp

POSaBIT Acquires Payments Solutions Provider Hypur for US$7.5 Million, Adding Over US$100 Million in Annualized Payment GMV

TORONTO & SEATTLE–(BUSINESS WIRE)–POSaBIT Systems Corporation (“POSaBIT” or the “Company”) (CSE: PBIT, OTC: POSAF), a premier point-of-sale and payments provider for the cannabis industry, today announced it has acquired certain assets from Hypur Inc. (“Hypur”), effective April 1, 2023, in a cash and equity transaction valued at up to US$7.5 million, implying a purchase price multiple of 1.4x 2022 revenue.1 Hypur is a leading provider of compliant, sustainable payment and bank compliance solu

Heritage Cannabis Receives First Purchase Order and Is Set to Begin Shipments of CBD Products to Brazil

TORONTO–(BUSINESS WIRE)—- $cann #cann–Heritage Cannabis Receives First Purchase Order and is Set to Begin Shipments of CBD Products to Brazil

Applied UV Reports Financial Results for Full Year 2022

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a global leading provider of patented, scientifically and clinically proven surface and air pathogen elimination and disinfection technologies (fixed, mobile, and HVAC), LED lighting products and premium hotel furnishings, announces today its financial results for the full year 2022. Recent Business Highlights Completed acquisition of Puro Lighting, LLC (“PURO”) and LED Supply Co. (“LED Suppl

Flora Growth Reports 2022 Year-End Financial Results: $37.2M in Revenue, 314% Growth Year-Over-Year

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, reported today its financial and operating results for the fiscal year ended December 31, 2022. All financial information is provided in U.S. dollars unless indicated otherwise. “In 2022, we not only met our revenue guidance but reported both quarterly and annual record revenue. This accomplishment was t

Columbia Care Opens Fifth Cannabist Dispensary in West Virginia

NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced it has opened its fifth dispensary in West Virginia. This is also the Company’s 34th Cannabist location in the U.S. Cannabist Huntington is located at 917 3rd Avenue and is now serving registered medical patients. “We are thrilled to we

Indiva to Report Fourth Quarter and Full Year Results Pre-Market on Tuesday April 18, 2023

LONDON, Ontario–(BUSINESS WIRE)–Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, will report its results for the year ended December 31, 2022 pre-market on Tuesday, April 18, 2023. CONFERENCE CALL – Tuesday, April 18, 2023 at 8:30 a.m. (EDT): The Company will host a conference call to discuss its results on Tuesday, April 18, 2023 at 8:30 a.m. (EDT). Interested participants can join by dialing 416-764-8658 o

Organigram Accelerates Focus on Vapes With Strategic Investment in Greentank

TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it has entered into a product purchase agreement (“Purchase Agreement”) with Green Tank Technologies Corp. (“Greentank”) a leading vaporization technology company and a subscription agreement (“Subscription Agreement”) with Greentank’s parent company, Weekend Holdings Corp (“Holdings”). The Purchase Agreement provides Organigram w